Keine Story von Kowa mehr verpassen.


  • 17.08.2010 – 16:33

    Kowa Announces First EU Marketing Authorisation for Pitavastatin Granted in the UK

    Wokingham, England, August 17, 2010 (ots/PRNewswire) - Kowa are delighted to announce that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a UK licence for their statin, Livazo(R) (pitavastatin). This follows the completion of the decentralized regulatory procedure, in which the MHRA delivered a positive outcome for pitavastatin whilst ...